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Abstract: Background: There are limited data on outcomes of patients with previous coronary artery bypass grafting 
(CABG) presenting acutely as ST-segment elevation myocardial infarction (STEMI) and undergoing primary 
percutaneous coronary intervention (PPCI). 
Objectives: To compare outcomes in STEMI patients undergoing PPCI with or without previous CABG surgery. 
Methods: An all-comer single-centre observational registry from a cardiothoracic centre in UK. All consecutive patients 
presenting for PPCI between 2007 and 2012 were included. Electronic records were used to extract relevant information. 
Mortality data were obtained from the Office of National Statistics. Overall median follow-up period was 1.7 years (intra-
quartile range 0.9-2.5). 
Results: Complete data were available for 2133 (97%) patients. 47-patients had previous history of CABG. Out of these, 
the infarct related artery (IRA) was native vessel in 22 and graft in 25 patients. Post re-vascularization TIMI flow was 
inferior in CABG cohort (<TIMI 3 flow in 17% vs. 10%, p=0.012) and they were less likely to achieve acute reperfusion 
(TIMI 0 in 9% vs. 3%, p=0012). In-hospital-mortality was not different in both groups (2%vs.4%, p=0.23). 30-day (HR 
0.54; 95%CI 0.17-1.73; P=0.301), 1-year-mortality (HR 0.77; 95%CI 0.31-1.87; P=0.56) and over a median follow-up of 
1.7 years (HR 1.1; 95%CI 0.54-2.27; P=0.79) were also not different.  
Conclusion: Patients presenting with STEMI to PPCI service with history of CABG are less likely to achieve acute 
reperfusion and have worse angiographic outcomes. Post PPCI, the prior CABG patients do not seem to have worse short-
term and long-term prognosis.  
Keywords: Acute myocardial infarction/STEMI, coronary bypass grafts, Primary PCI. 
INTRODUCTION 
 Obstructive coronary artery disease (CAD) leads to 
myocardial ischaemia, which causes significant morbidity 
and mortality [1, 2]. Myocardial revascularisation is the 
mainstay treatment of CAD for almost half a century. 
Coronary artery bypass grafting (CABG) has been used in 
clinical practice since 1960s and is the preferred reperfusion 
therapy in patients with multi-vessel disease (MVD), 
significant left main stem disease, MVD with diabetes and 
patientÕs with high SYNTAX scores (>22) [3-9]. Despite 
better use of secondary prevention measures in patients with 
history of CABG, the advancement of native coronary artery 
atherosclerosis and accelerated stenosis in saphenous vein 
grafts (SVG) remains an issue. Serial angiographic follow-up  
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studies have demonstrated that approximately 10% of SVG 
occlude in the first year after which there is a continued 
deterioration, which accelerates with the grafts age [10, 11]. 
Deterioration in these grafts occurs at a rate of at least 2% to 
5% annually [12-16]. Hence, patients with prior CABG are 
likely to suffer with acute ST-segment elevation myocardial 
infarction (STEMI) because of either acute native vessel or 
graft occlusion.  
 Fibrinolytic therapy is less effective in this prior CABG 
population [17, 18]. In the developed world, primary 
percutaneous therapy (PPCI) is the preferred and most 
widely used intervention for patient presenting with acute 
STEMI. Current guidelines for patients presenting with 
STEMI do not explicitly describe the management of this 
complex group of patients, as there is limited evidence 
available. A sub-study of APEX-AMI (Assessment of 
Pexelizumab in Acute Myocardial Infarction) trial showed 
that prior CABG patients with STEMI were less likely to 
undergo acute reperfusion, had worse angiographic outcome 
and higher 90-day mortality [19]. A sub-study of  
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HORIZONS-AMI (Harmonizing Outcomes With 
Revascularisation and Stents in Acute Myocardial Infarction) 
also showed similar results with greater incidence of major 
adverse cardiovascular events (MACE) and mortality at 3 
years [20]. Long-term longitudinal outcomes in an 
unselected all-comer population have not been extensively 
studied. This study aimed to study the long-term outcomes of 
PPCI in patients with previous CABG in the real world. 
METHODS 
 Setting. Single centre observational retrospective study 
from a large volume cardiothoracic centre providing PPCI 
service to 1.8 million population in UK.  
 Patients. All patients presenting for PPCI from January 
2007 to June 2012 were included, with no exclusion criteria. 
Regional PPCI information processing database (Infoflex) 
for national audit of PCI was used to retrieve relevant 
information - patient demographics (age, sex, past medical 
history and risk factors for CAD) and procedural details 
(culprit vessel, flow after PPCI and success of procedure). 
The relevant medical history included the following - 
diabetes mellitus, smoking history, hypertension, 
hypercholesterolaemia, peripheral vascular disease, cerebro-
vascular accidents, previous myocardial infarction, previous 
percutaneous intervention, renal disease (creatinine > 
200umol/l, renal dialysis patients, functioning transplant), 
family history of CAD and extent of CAD. All-cause 
mortality till the end of study was obtained form the Office 
of National Statistics (ONS), UK.  
 Statistical analysis. Data are presented as mean ± SD for 
continuous variables and as percentage or proportion for 
discrete variables. Data was summarised with descriptive 
statistics using Fisher Exact test for categorical variables. 
Kaplan-Meier survival curves and log-rank testing were used 
to compare the outcomes between CABG and non-CABG 
groups. Backward stepwise Cox-Regression analysis was 
performed to ascertain which factors influenced mortality. 
SPSS version 21.0 (SPSS, Inc) was used for data analysis 
and a two-tailed p-value of .05 was regarded as statistically 
significant.  
 
Ethical Approval 
 This work was observational study evaluating outcomes 
from registry-based dataset. It was approved by the local 
clinical governance department as an audit project and did 
not require any further approval from local or national 
research ethics committee as per the UK guidelines.  
RESULTS 
 Between 2007 and 2012, a total of 2202 patients 
presented with STEMI to our regional PPCI centre (Fig. 1). 
Of these, complete data was available for 2133 (97%) 
patients. This group consisted of 1564 (73%) males (mean 
age= 61.27±12.4 years) and 569 (27%) females (mean age= 
66.78±12.7 years). 47 (2%) patients had previous history of 
CABG. Out of these, infarct related artery (IRA) was native 
vessel in 22 patients and graft in the other 25 patients. Some 
differences were noted in baseline characteristics in the two 
groups - prior CABG versus no prior CABG (Table 1). 
Patients with no prior history of CABG were more likely to 
be smokers and present with single vessel disease (1VD). On 
the contrary, patients with prior history of CABG were more 
likely to have peripheral vascular disease (PVD), triple 
vessel disease, suffered previous MI and had previous PCI. 
Both group had similar representation of patients presenting 
with cardiogenic shock (2% versus 2%, p=1.000).  
 From the 1603 patients for whom reperfusion data was 
available, post re-vascularization the ÔThrombolysis In 
Myocardial InfarctionÕ (TIMI) flow was inferior in the prior 
CABG cohort (<TIMI 3 flow in 17% vs. 10%, p=0.012) and 
they were less likely to achieve acute reperfusion (TIMI 0 in 
9% vs. 3%, p=0012). 
 Post PPCI, analysis of in-hospital major adverse 
cardiovascular and cerebral events (MACCE) showed that 
prior CABG patients suffered more CVA than the other 
group (Table 2). However, post-procedure MI, re-
intervention and all-cause death did not differ significantly 
between the two groups.  
 In-hospital mortality, though numerically double in 
CABG group, was not statistically different between the two  
 
 
Fig. (1). Flow chart of number of patients recruited in each arm of the study. 
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groups (2% vs. 4%, p=0.228). Furthermore, 30-day mortality 
(HR 0.54; 95% CI 0.17-1.73; P=0.301) and 1-year mortality 
(HR 0.77; 95% CI 0.31-1.87; P=0.559) were also not 
different in both groups. Over the long-term follow-up 
(median 1.7 years), there was a trend towards higher 
mortality in previous CABG cohort that did not achieve 
statistical significance (10% vs. 17%; P=0.12). Within the 
prior CABG group, there was a trend towards higher 
mortality in the graft IRA patients versus the native IRA 
patients (24% vs. 9%, P=0.253). 
 Even after accounting for all the confounding factors 
using the cox-regression analysis, previous CABG history 
did not show any significant influence on the mortality after 
PPCI (HR 1.1; 95% CI 0.54-2.27; P=0.79) (Fig. 2). 
Independent predictors of mortality in both groups were the 
traditional risk factors: - older age, history of renal disease 
and extent of coronary artery (Table 3).  
DISCUSSION 
 This large longitudinal observational study, which 
collected data of patients presenting to PPCI service over a 
period of five and a half years, didnÕt show any statistical 
difference in the primary outcome (death) in patients with or 
without previous history of CABG. As expected, patients 
with prior CABG were more likely to have history of 
Table 1. Baseline characteristics of patients presenting with STEMI to PPCI service. 
  No CABG (n=2086) Previous CABG (n=47) P Value 
Male 1525 (73%) 39 (83%) 0.181 
Age (years) 62.7±12.8 64.8±10.4 0.169 
Diabetes Mellitus 232 (11%) 5 (11%) 1.000 
Current smoker 696 (33%) 11 (23%) 0.039 
Hypertension 623 (30%) 20 (43%) 0.076 
Hypercholesterolaemia 787 (38%) 22 (47%) 0.225 
PVD 71 (3%) 5 (11%) 0.024 
CVA 52 (2.5%) 1 (2.2%) 1.000 
Previous MI 355 (17%) 24 (51%) <0.001 
Previous PCI 136 (6%) 11 (23%) <0.001 
Renal Disease  20 (1%) 1 (2%) 0.375 
Family history of CAD 385 (18%) 11 (23%) 0.446 
Extent of CAD     <0.001 
1VD 1163 (56%) 13 (28%)   
2VD 550 (26%) 7 (15%)   
3VD 366 (17%) 27 (57%)   
Cardiogenic Shock at presentation 44 (2%) 1 (2%) 1.000 
Abbreviations: PVD, peripheral vascular disease; CVA, cerebrovascular accident; 1VD, one vessel disease; 2VD, two-vessel disease, 3VD, triple-vessel 
disease; MI, myocardial infarction; CAD, coronary artery disease. 
 
Table 2. In-hospital MACCE post PPCI in both group of patients. 
 Non-CABG 
(n=2086) 
Prior-CABG 
(n=47) 
P Value 
Death  39 (2%) 2 (4%) 0.228 
MI 4 0 1.000 
CVA/TIA  2 (<0.1%) 1 (2%) 0.044 
Re-intervention  6 (0.2%) 0 1.000 
MACCE* 51 (2.4%) 3 (6.3%) 0.11 
*MACCE major adverse cardiovascular and cerebrovascular events defined as composite of all-cause death, myocardial infarction (MI), re-intervention and 
stroke. 
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previous MI, PVD, triple vessel disease and also previous 
coronary intervention. Interestingly, even though mortality 
rates in both groups didnÕt achieve statistical difference, the 
patients with prior CABG were less likely to achieve acute 
reperfusion and had worse angiographic outcome as assessed 
by TIMI flow.  
 A substudy of a large trial (APEX-AMI) of PPCI in 
STEMI patients by Welsh et at showed increased 90-day 
mortality in patients with prior CABG (11.9% vs 4.9%; 
P<0.001) [19]. In keeping with this study we further 
analysed mid-term outcomes in our population and the 90-
day mortality in the prior CABG patients was no worse (HR 
1.06; 95% CI 0.39-2.88; P value=0.909). Hence, there is 
plausible difference in mortality outcomes between our study 
and APEX-AMI. However, similar to our study, Welsh et at 
showed poorer angiographic outcomes and worse TIMI flow 
post PPCI in CABG group. We also noted that in the 
substudy of APEX-AMI, PCI was performed less frequently 
in the CABG group (78.9% vs 93.9%).  
 Another large study (n=1649) performed by Bench et al 
in several New York hospitals showed higher in-hospital 
mortality in CABG group (6.5% vs 2.2%; P=0.012) and also 
higher rate of MACE (6.5% vs 2.7%; P=0.039) [21]. On the  
 
 
contrary, our study did not achieve statistical difference in 
both in-hospital mortality (2% vs. 4%, p=0.228) and MACE 
(6.3% vs 2.4%; P=0.11). This may be because our data 
represented smaller prior CABG group (47; 2.2%) compared 
to Bench et alÕs study (93; 5.6%).  
 A substudy of HORIZONS-AMI trial also studied the 
long-term outcomes in both the prior CABG and the non-
CABG groups presenting with STEMI to the PPCI service 
[20]. In this study too, no statistical difference in mortality 
was noted between both the groups over a follow-up period 
of 3 years (HR 0.37; 95% CI 0.10 - 1.34; P=0.13). This was 
the only other study to ours that analysed long-term 
outcomes in both the groups. Similar to our study, they also 
showed higher occurrence of CVA post PPCI in the prior 
CABG group (0.7% vs 2.9%; P=0.008). 
 For all the four studies mentioned above including ours, 
it is still not clear if patients with previous CABG who 
present to the PPCI service with STEMI have higher 
mortality after PCI compared to the non CABG group. 
Nevertheless, all studies concur that previous CABG patients 
are less likely to achieve acute reperfusion and have worse 
TIMI flow outcomes post PCI. It is also important to note  
 
 
 
Fig. (2). Survival Curves: a) Kaplan-Meier survival curve (non-adjusted for demographics) for the patients presenting with STEMI with or 
without prior history of CABG. b) Cox-Regression survival curve (adjusted for demographics). 
Table 3. Independent predictors of mortality. 
Variables Hazard Ratios  Confidence Interval  P value 
Age 1.06 95% CI 1.05-1.08 P<0.005 
History of Renal disease  2.45  95% CI 1.24-4.85 P=0.01 
Extent of Coronary Disease 1.23  95% CI 1.04-1.45 P=0.01 
Peripheral Vascular Disease 1.59  95% CI 1.00-2.52 P=0.068 
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that prior CABG patientÕs are more likely to suffer CVA 
post PPCI.  
 The final conclusion from all the respective studies is that 
all patients with prior history of CABG who present with 
STEMI, should be offered PPCI with extra caution and 
informed decision about possible extra risk of stroke and 
poor angiographic outcome.  
Study Limitations 
 There are several potential limitations of our study. 
Firstly, as this a longitudinal follow-up study, we can only 
comment on the median follow-up duration which was 1.7 
years since we started the data collection. Secondly, as our 
study was a retrospective observational study, the results 
ought to be contemplated as hypothesis generating. Finally, 
even though our CABG population in the study are similar to 
other studies (2%), the overall number of patients in this 
group was small.  
CONCLUSION 
 Patients presenting with STEMI to PPCI service with 
prior history of CABG are less likely to achieve acute 
reperfusion and have worse angiographic outcomes, 
particularly where infarct related artery is a graft. However, 
this did not result in any significant increase in the in-
hospital, 30-days and 1-year mortality. Long-term follow 
over a median duration of 1.7 years, also did not show any 
significant increase in mortality in the previous CABG 
cohort.  
ABBREVIATIONS 
1VD = Single vessel disease  
CAD = Coronary artery disease  
CABG = Coronary artery bypass grafting  
IRA = Infarct related artery  
MACCE = Major adverse cardiovascular and cerebral 
events  
MACE = Major adverse cardiovascular events  
MVD = Multi-vessel disease  
PPCI = Primary percutaneous therapy  
PVD = Peripheral vascular disease  
STEMI = ST-segment elevation myocardial 
infarction  
SVG = Saphenous vein grafts  
TIMI = Thrombolysis In Myocardial Infarction  
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